Photo from Michael Chuong/X
May 14, 2024, 13:28
Michael Chuong: Excited that our phase 1 trial of ablative reRT is open
Michael Chuong, Lead GI Radiation Oncologist at Miami Cancer Institute, shared on X:
“Excited our phase 1 trial of ablative reRT is open at the Miami Cancer Institute Research. .
- Based on our data (PMID: 35146215)
- 50 Gy/5 fx
- Primary/metastatic lesions in abdomen/pelvis
- GI abutment ok, not invasion
- Maybe reRT can be more than just palliative?”
Source: Michael Chuong/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 22, 2025, 16:00
Feb 22, 2025, 15:54
Feb 22, 2025, 15:48
Feb 22, 2025, 15:33
Feb 22, 2025, 15:14
Feb 22, 2025, 15:04
Feb 22, 2025, 14:43
Feb 22, 2025, 14:10
Feb 22, 2025, 13:28
Feb 22, 2025, 13:10
Feb 22, 2025, 13:04